Evidence map›Paper›PMID 31814084›Full record

ArticleGeroScience2020

Lipoteichoic acid from the cell wall of a heat killed Lactobacillus paracasei D3-5 ameliorates aging-related leaky gut, inflammation and improves physical and cognitive functions: from C. elegans to mice.

Shaohua Wang, Shokouh Ahmadi, Ravinder Nagpal, Shalini Jain, Sidharth P Mishra, Kylie Kavanagh, Xuewei Zhu, Zhan Wang, Donald A McClain, Stephen B Kritchevsky and 2 more

Abstract read
In one paragraph

Article in GeroScience, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 115 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
115citing papers in PubMed, 2 pooled it
6.4field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

115 citing papers in PubMed, 2 syntheses or guidelines pooled it, 205 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Review
  5. Review
  6. Review
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Review
  14. Review
  15. Review
  16. Review
  17. Article
  18. Harnessing postbiotics for liver health: Emerging perspectives.World journal of gastrointestinal pharmacology and therapeutics · 2025
    Review
  19. Review
  20. Article

55 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 2 countries.

Shaohua WangDepartment of Internal Medicine-Molecular Medicine, Wake Forest School of Medicine, Winston-Salem, NC, USA.
Shokouh AhmadiDepartment of Internal Medicine-Molecular Medicine, Wake Forest School of Medicine, Winston-Salem, NC, USA.
Ravinder NagpalDepartment of Internal Medicine-Molecular Medicine, Wake Forest School of Medicine, Winston-Salem, NC, USA.
Shalini JainDepartment of Endocrinology and Metabolism, Wake Forest School of Medicine, Winston-Salem, NC, USA.
Sidharth P MishraDepartment of Internal Medicine-Molecular Medicine, Wake Forest School of Medicine, Winston-Salem, NC, USA.
Kylie KavanaghDepartment of Internal Medicine-Molecular Medicine, Wake Forest School of Medicine, Winston-Salem, NC, USA.
Xuewei ZhuDepartment of Internal Medicine-Molecular Medicine, Wake Forest School of Medicine, Winston-Salem, NC, USA.
Zhan WangDepartment of Internal Medicine-Molecular Medicine, Wake Forest School of Medicine, Winston-Salem, NC, USA.
Donald A McClainDepartment of Endocrinology and Metabolism, Wake Forest School of Medicine, Winston-Salem, NC, USA.
Stephen B KritchevskyDepartment of Gerontology and Geriatric Medicine, Wake Forest School of Medicine, Winston-Salem, NC, USA.
Dalane W KitzmanDepartment of Gerontology and Geriatric Medicine, Wake Forest School of Medicine, Winston-Salem, NC, USA.
Hariom YadavDepartment of Internal Medicine-Molecular Medicine, Wake Forest School of Medicine, Winston-Salem, NC, USA. hyadav@wakehealth.edu.ORCID http://orcid.org/0000-0003-4504-1597
Wake Forest University · USUniversity of Tasmania · AU

Funding

Study of Muscle, Mobility and Aging: SOMMA2R01AG059416 · NIA · CALIFORNIA PACIFIC MED CTR RES INSTITUTE · PI STEVEN RON CUMMINGS, Peggy Mannen Cawthon · 2018 to 2026
$70.3M
Wake Forest Claude D. Pepper OAIC - RenewalP30AG021332 · NIA · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI Jamie Nicole Justice · 2002 to 2026
$36.4M
Wake Forest Clinical and Translational Science AwardUL1TR001420 · NCATS · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI ARD, JAMY D, FOLEY, KRISTIE L · 2015 to 2023
$32.3M
Wake Forest Alzheimer's Disease Core CenterP30AG049638 · NIA · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI RAPP, STEPHEN R · 2016 to 2020
$12.2M
Research Centers Collaborative Network RenewalU24AG058556 · NIA · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI KRITCHEVSKY, STEPHEN B., LEDERMAN, STEPHANIE · 2018 to 2025
$7.5M
Enhancing and expanding the CGC Strain CollectionP40OD010440 · OD · UNIVERSITY OF MINNESOTA · PI Ann E. Rougvie · 2012 to 2026
$7.5M
REHAB-HF: A Trial of Rehabilitation Therapy in Older Acute Heart Failure PatientsR01AG045551 · NIA · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI KITZMAN, DALANE W · 2014 to 2018
$6.8M
Pepper OAIC Coordinating CenterU24AG059624 · NIA · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI DALANE W KITZMAN · 2018 to 2026
$6.0M
Wake Forest Clinical and Translational Science AwardKL2TR001421 · NCATS · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI MILLER, DAVID P · 2015 to 2023
$5.8M
Exercise Intolerance in Older HFPEF PatientsR01AG018915 · NIA · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI KITZMAN, DALANE W · 2001 to 2019
$5.2M
Laboratory Animal & Comparative Medicine TrainingT32OD010957 · OD · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI J. MARK CLINE · 2012 to 2026
$4.3M
Combining assessment of cognition, eye movement, and gait in naturalistic settings to differentiate subclinical Alzheimer's pathology.R01AG052419 · NIA · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI KRITCHEVSKY, STEPHEN B., LAURIENTI, PAUL · 2017 to 2022
$4.2M
BLRD VA I01 BX005109NCATS NIH HHS KL2 TR001421NCATS NIH HHS UL1 TR001420NHLBI NIH HHS R01 HL132035NHLBI NIH HHS R01HL132035NHLBI NIH HHS R01HL142930NIA NIH HHS P30 AG021332NIA NIH HHS P30 AG049638NIA NIH HHS R01 AG018915NIA NIH HHS R01 AG045551NIA NIH HHS R01 AG052419NIA NIH HHS R01 AG059416NIA NIH HHS U13 AG040938NIA NIH HHS U24 AG058556NIA NIH HHS U24 AG059624NIDDK NIH HHS R01 DK081842NIDDK NIH HHS R01DK081842NIH HHS P40 OD010440NIH HHS T32 OD010957
6 · The paper itself

Abstract

Increased inflammation associated with leaky gut is a major risk factor for morbidity and mortality in older adults; however, successful preventive and therapeutic strategies against these conditions are not available. In this study, we demonstrate that a human-origin Lactobacillus paracasei D3-5 strain (D3-5), even in the non-viable form, extends life span of Caenorhabditis elegans. In addition, feeding of heat-killed D3-5 to old mice (> 79 weeks) prevents high- fat diet-induced metabolic dysfunctions, decreases leaky gut and inflammation, and improves physical and cognitive functions. D3-5 feeding significantly increases mucin production, and proportionately, the abundance of mucin-degrading bacteria Akkermansia muciniphila also increases. Mechanistically, we show that the lipoteichoic acid (LTA), a cell wall component of D3-5, enhances mucin (Muc2) expression by modulating TLR-2/p38-MAPK/NF-kB pathway, which in turn reduces age-related leaky gut and inflammation. The findings indicate that the D3-5 and its LTA can prevent/treat age-related leaky gut and inflammation.

Indexed as

Lacticaseibacillus paracaseiAgingAnimalsCaenorhabditis elegansCell WallCognitionHot TemperatureInflammationLipopolysaccharidesMiceTeichoic AcidsLipopolysaccharideslipoteichoic acidTeichoic AcidsAgingCell wallCognitionGoblet cellInflammationLeaky gutLipoteichoic acidMetabolismMucinPhysical functionProbiotics

Identifiers

PMID31814084
PMCPMC7031475
OpenAlexW2992403227

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.